Skip to main content
SpringerLink
Log in

Cimetidine reduces weight and improves metabolic control in overweight patients with Type 2 diabetes

  • Paper
  • Published:
International Journal of Obesity Submit manuscript

Abstract

OBJECTIVE: To investigate the weight-reducing effect of cimetidine in overweight patients with Type 2 diabetes.

DESIGN: A 12-week clinical intervention study of 400 mg cimetidine prescribed three times daily in a randomised, double-blind, placebo-controlled design.

SUBJECTS: Forty-three overweight patients with Type 2 diabetes (age 18–65 y, body mass index (BMI) 27.2–48.2 kg/m2).

MEASUREMENTS: Body weight, BMI, body fat, waist and hip circumference, waist/hip ratio, blood pressure, fasting blood glucose, HbA1c, plasma concentrations of insulin, insulin/glucose ratio and lipids at the start and after 12 weeks, and daily recordings of appetite.

RESULTS: Subjects given cimetidine (n=19) and placebo (n=24) lost 5.0±2.2 kg (mean±s.d.) and 1.3±1.1 kg, respectively. Significant reductions were observed in appetite, body fat (29.9±6.6% to 25.3±7.4%), waist circumference (111.5±10.3 cm to 107.4±10.6 cm), waist/hip ratio (0.96±0.08 to 0.94±0.08), and systolic and diastolic blood pressure (reductions of 6.9±11.4 mm Hg and 6.0±6.6 mm Hg, respectively) in cimetidine group only. Significant decreases in fasting concentrations of blood glucose, HbA1c, plasma insulin, insulin/glucose ratio, plasma triglycerides and a significant increase in plasma high-density lipoprotein cholesterol were observed in the cimetidine group only.

CONCLUSIONS: Cimetidine reduces appetite and body weight, and improves metabolic control in overweight subjects with Type 2 diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Laboratory of Gastroenterology, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway

    G Støa-Birketvedt & J Florholmen

  2. Biochemical Department, University Hospital of Tromsø, Tromsø, Norway

    OC Ingebretsen

  3. Medical Department, Central Hospital of Akershus, Nordbyhagen, Norway

    PN Paus & R Ganss

Authors
  1. G Støa-Birketvedt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. PN Paus
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R Ganss
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. OC Ingebretsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J Florholmen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Støa-Birketvedt, G., Paus, P., Ganss, R. et al. Cimetidine reduces weight and improves metabolic control in overweight patients with Type 2 diabetes. Int J Obes 22, 1041–1045 (1998). https://doi.org/10.1038/sj.ijo.0800721

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0800721

  • Springer Nature Limited

Keywords

Search

Navigation